A Double-Edged Sword: Neurologic Complications and Mortality in Extracorporeal Membrane Oxygenation Therapy for COVID-19–Related Severe Acute Respiratory Distress Syndrome at a Tertiary Care Center

References

1. 1.↵
   1. Alshahrani MS,
   2. Sindi A,
   3. Alshamsi F, et al

   . Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018;8:3 doi:10.1186/s13613-017-0350-x pmid:29330690

   CrossRefPubMedGoogle Scholar
2. 2.↵
   1. Sultan I,
   2. Habertheuer A,
   3. Usman AA, et al

   . The role of extracorporeal life support for patients with COVID-19: preliminary results from a statewide experience. J Card Surg 2020;5:1410–13 doi:10.1111/jocs.14583 pmid:32333431

   CrossRefPubMedGoogle Scholar
3. 3.↵
   1. Jacobs JP,
   2. Stammers AH,
   3. St Louis J, et al

   . Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients. ASAIO J 2020 2020;66:722–30 doi:10.1097/MAT.0000000000001185 pmid:32317557

   CrossRefPubMedGoogle Scholar
4. 4.↵
   1. Henry BM,
   2. Lippi G

   . Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care 2020;58:27–28 doi:10.1016/j.jcrc.2020.03.011 pmid:32279018

   CrossRefPubMedGoogle Scholar
5. 5.↵
   1. Lorusso R,
   2. Gelsomino S,
   3. Parise O, et al

   . Neurologic injury in adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure: findings from the Extracorporeal Life Support Organization Database. Crit Care Med 2017;45:1389–97 doi:10.1097/CCM.0000000000002502 pmid:29221234

   CrossRefPubMedGoogle Scholar
6. 6.↵
   1. Peek GJ,
   2. Mugford M,
   3. Tiruvoipati R, et al

   . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374:1351–63 doi:10.1016/S0140-6736(09)61069-2 pmid:19762075

   CrossRefPubMedWeb of ScienceGoogle Scholar
7. 7.↵
   1. Radmanesh A,
   2. Raz E,
   3. Zan E, et al

   . Brain imaging findings in COVID-19: a single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol 2020;41:1179–83 doi:10.3174/ajnr.A6610 pmid:32467191

   Abstract/FREE Full TextGoogle Scholar
8. 8.↵
   1. Heman-Ackah SM,
   2. Su S,
   3. Spadola M, et al

   . Neurologically devastating intraparenchymal hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation: a case series. Neurosurgery 2020;87:E147–51 doi:10.1093/neuros/nyaa198 pmid:32424429

   CrossRefPubMedGoogle Scholar
9. 9.↵
   1. Kowalewski M,
   2. Fina D,
   3. Słomka A, et al

   . COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review. Crit Care 2020;24:205 doi:10.1186/s13054-020-02925-3 pmid:32384917

   CrossRefPubMedGoogle Scholar